Vanessa Feudo

Dr. Vanessa Feudo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
FDFrancesco Dondi
Francesco Dondi
AMAlberto Miceli
Alberto Miceli
GRGuido Rovera
Guido Rovera
VFVanessa Feudo
Vanessa Feudo
CBClaudia Battisti
Claudia Battisti
GSGiulia Santo
Giulia Santo
Introduction: The term theragnostic refers to the combination of a predictive imaging biomarker with a therapeutic agent. The promising application of prostate-specific membrane antigen (PSMA)-based radiopharmaceuticals in the imaging and treatment of prostate cancer (PCa) patients opens the way to investigate a possible role of PSMA-based radiopharmaceuticals in cancers beyond the prostate. Therefore, the aim of this review was to evaluate the role of 177Lu-PSMA radioligand therapy (RLT) in malignancies other than prostate cancer by evaluating preclinical, clinical studies, and ongoing clinical trials. Methods: An extensive literature search was performed in three different databases using different combinations of the following terms: “Lu-PSMA”, “177Lu-PSMA”, “preclinical”, “mouse”, “salivary gland cancer”, “breast cancer”, “glioblastoma”, “solid tumour”, “renal cell carcinoma”, “HCC”, “thyroid”, “salivary”, “radioligand therapy”, and “lutetium-177”. The search had no beginning date limit and was updated to April 2024. Only articles written in English were included in this review. Results: A total of four preclinical studies were selected (breast cancer model n = 3/4). PSMA-RLT significantly reduced cell viability and had anti-angiogenic effects, especially under hypoxic conditions, which increase PSMA binding and uptake. Considering the clinical studies (n = 8), the complexity of evaluating PSMA-RLT in cancers other than prostate cancer was clearly revealed, since in most of the presented cases a sufficient tumour radiation dose was not achieved. However, encouraging results can be found in some types of diseases, such as thyroid cancer. Some clinical trials are still ongoing, and results from prospective larger cohorts of patients are awaited. Conclusions: The need for larger patient cohorts and more RLT cycles administered underscores the need for further comprehensive studies. Given the very preliminary results of both preclinical and clinical studies, ongoing clinical trials in the near future may provide stronger evidence of both the safety and therapeutic efficacy of PSMA-RLT in malignancies other than prostate cancer.

23 November 2023 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
AVAntonio De Vita
Antonio De Vita
IBIsabella Bruno
Isabella Bruno
SBSilvia Baroni
Silvia Baroni
GMGiacomo Moretti
Giacomo Moretti
FTFederica Tempestini
Federica Tempestini
GLGaetano Antonio Lanza
Gaetano Antonio Lanza

18 June 2025 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
AFAnita Florit
Anita Florit
WNWyanne A. Noortman
Wyanne A. Noortman
Nicolò BizzarriNicolò Bizzarri
Nicolò Bizzarri
Tina PasciutoTina Pasciuto
Tina Pasciuto
VFVanessa Feudo
Vanessa Feudo
ACAngela Collarino
Angela Collarino


Verified
Journal Article
Open access
PDF file
RTRaphael Thomasset
Raphael Thomasset
DADomenico Antonio Agostino
Domenico Antonio Agostino
VFVanessa Feudo
Vanessa Feudo
BMbianca masturzo
bianca masturzo
PMPaolo Manzoni
Paolo Manzoni
Livio LeoLivio Leo
Livio Leo
Background: Neonatal aortic coarctation (CoA) remains difficult to diagnose before hemodynamic deterioration occurs after ductal closure. Pulse wave velocity (PWV) may reflect functional vascular alterations associated with CoA. Methods: A simplified hemodynamic mathematical model describing pulse wave propagation across aortic coarctation has been developed. The model is based on conservation of energy principles and incorporates simplified assumptions regarding arterial compliance to relate PWV changes to systolic–diastolic pressure. Results: The model suggests a nonlinear relationship between PWV reduction distal to the coarctation and pressure excursion damping. Specifically, a twofold PWV reduction corresponds theoretically to an approximately fourfold reduction in systolic–diastolic pressure variation. The derived relationships were shown to be conceptually consistent with the Moens–Korteweg formulation and Laplace law. Conclusions: This theoretical framework supports the physiological plausibility of combining PWV assessment with pressure-gradient evaluation in neonatal CoA screening. Future studies are required to validate the model in clinical settings and define diagnostic thresholds.